ALBT - Company ID 0001630212
The table below shows Avalon GloboCare Corp.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | $350.10K | $350.41K | $349.80K | $345.16K | $327.89K |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
Avalon GloboCare Corp. reported annual revenue of $1.33M for fiscal year 2024. That is up 6.2% from $1.26M in fiscal 2023. Over the 9 fiscal years shown, annual revenue grew from $616.45K (FY 2016) to $1.33M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| - |
| - |
| - |
| Operating income | -$2.72M | -$76.19K | -$3.89M | -$1.79M | -$1.27M | -$1.50M |
| Income tax | - | - | - | - | - | - |
| Net income | -$4.48M | -$254.27K | -$13.46M | -$2.48M | -$1.68M | -$2.13M |
| EPS (diluted) | -$0.50 | -$0.06 | -$6.22 | -$1.43 | -$1.82 | -$2.85 |